Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics, Millipore

Premium
Bioinformatics has released a new research report entitled “Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Biotech Industry.

The report states that “while the use of synthetic siRNA is still relatively new, the industrial market segment will continue strong growth over the near term,” the company said. “Among current industrial users of siRNA, an overall growth rate of 9 percent is projected for the next twelve months. In addition, about one-third of survey respondents indicate that they do not now conduct RNAi experiments but plan to do so in the upcoming months, implying further market growth potential.”
 

 
Millipore has recently introduced AdenoSilence shRNA-expression vectors.
 
According to the company, the vectors target the human druggable genome and include major protein classes amenable to small-molecule intervention such as kinases, GPCRs, ion channels, proteases, nuclear hormone receptors, secreted proteins, and receptors.
 
The vectors are available in three different sequence variants sold individually or as a kit containing all three.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.